NCT03683797 is a NA clinical trial of Post-discharge call in Care Transitions, sponsored by NYU Langone Health.

Who is sponsoring NCT03683797?

NCT03683797 is sponsored by NYU Langone Health.

What drugs are being tested in NCT03683797?

Interventions in NCT03683797: Post-discharge call.

What condition does NCT03683797 study?

NCT03683797 studies Care Transitions.

Is NCT03683797 still recruiting?

NCT03683797 is currently completed. Last updated 20 July 2021.

Last reviewed 2021-07-20 · How we verify

NCT03683797

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission

Completed NA Last updated 20 July 2021

What this trial tests

NA trial testing Post-discharge call in Care Transitions in 3,267 participants. Completed in 22 March 2019.

Timeline

13 August 2018

Primary endpoint
30 November 2018

22 March 2019

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	3,267
Start date	13 August 2018
Primary completion	30 November 2018
Estimated completion	22 March 2019
Sites	1 location across United States

Drugs / interventions tested

Post-discharge call

Conditions studied

Care Transitions — all drugs for Care Transitions →

Sponsor

NYU Langone Health — full company profile →

Who can join

Eligibility, any sex, with Care Transitions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

NYU Langone Health patients receive a call from a clinical care coordinator after they are discharged from the hospital (within 1-3 days). The current study is testing the efficacy of this program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Care Transitions

Currently open trials in the same condition.

NCT06203509 — Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness · NA · recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03683797 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 20 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03683797.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing